Table 1.

Eligibility criteria

Inclusion criteria
1	Anxiety disorder, mood disorder, or adjustment disorder is the main diagnosis (most interfering and severe)a
2	The patient is over 18 years of age
3	The patient is fluent in the language in which therapy is performed (Spanish in the present study)
4	The patient is able to attend to the evaluation and treatment sessions and signs the informed consent form
5	Patients taking pharmacological treatment for their emotional disorder are asked to maintain the same dosages and medications for at least 3 months prior to enrolling in the study and during the whole treatmentb
Exclusion criteria
1	The patient presents a severe condition that would require to be prioritized for treatment, so that an interaction between both interventions cannot be ruled out. These include a severe mental disorder (bipolar disorder, schizophrenia, or an organic mental disorder),suicide risk at the time of assessment, or substance use in the last three months (excluding cannabis, coffee, and / or nicotine)
2	The patient has previously received 8 or more sessions of psychological treatment with clear and identifiable CBT principles within the past 5 years.

^aThe following disorders will be included based on DSM-IV-TR diagnostic criteria [21]: major depression disorder, dysthymic disorder, panic disorder, agoraphobia, obsessive-compulsive disorder, generalized anxiety disorder, posttraumatic stress disorder, social anxiety disorder, hypochondria, and adjustment disorders. Patients with unspecified anxiety disorders and unspecified depressive disorders will also be included as they are frequent in public settings

^bIf medication stability is not possible, the participant’s data will be treated separately in the analyses